TMX Group Limited (X:CA) Presents at Scotiabank's 27th Annual Financials Summit Transcript

TMX Group said momentum is broad-based across its business segments and highlighted three transactions totaling roughly $2 billion of inorganic investment, including the recently referenced Cboe and MEMX deals. Management expressed confidence in extending growth into H2 2026 and 2027, while Scotiabank estimated the company could surpass its $2 billion revenue target—originally envisioned by end-2029—as early as 2027. CFO David Arnold said that assessment was directionally correct and potentially conservative, citing $975 million of organic revenue in the first half of 2026.

Analysis

The investable issue is not the top-line aspiration but whether TMX can translate a larger, more diversified transaction footprint into durable operating leverage. Exchange businesses have high incremental margins once technology and regulatory infrastructure are absorbed; if acquired venues contribute without meaningful fee compression or integration expense, consensus EBITDA estimates for 2027-28 are likely too low. The principal second-order beneficiary is CBOE: greater cross-border competition validates electronic derivatives and data-marketplace valuations, but TMX's expanded footprint could pressure CBOE's Canadian-linked growth opportunities and institutional order-flow economics over time.

Near term, X:CA should receive a multiple-supportive rerating if management quantifies pro forma revenue, synergy targets, and leverage trajectory at the next results cycle. The critical risk is that revenue run-rate extrapolation embeds unusually strong trading, listings, and market-data conditions; those are cyclical and can reverse quickly if Canadian equity issuance or volatility normalizes. Over 6-18 months, the key falsifiers are acquisition-related expense exceeding disclosed expectations, net-debt/EBITDA remaining elevated rather than declining after close, or organic recurring-revenue growth decelerating despite the added assets.

Contrarian view: investors may over-credit revenue scale while underpricing regulatory and integration complexity. Exchange acquisitions create value only if liquidity remains intact after migrations and clients accept common technology, connectivity, and data pricing; a modest delay can defer the expected margin inflection by several quarters. That said, the market may also be too focused on a Canada-listed exchange multiple: successful execution could justify valuation convergence toward global market-infrastructure peers, particularly if recurring data, analytics, and post-trade revenues become a larger share of mix.

Key Decisions for Investors

• Accumulate X:CA on post-event weakness rather than chase the conference-driven move; target a 6-12 month position sized for a rerating on disclosed pro forma EBITDA/synergies. Reassess if organic revenue growth falls below management's implied run-rate for two consecutive quarters or leverage does not begin to decline after transaction closings.
• Use a relative-value structure: long X:CA / short CBOE in dollar-neutral size over 6-12 months if TMX demonstrates integration milestones and recurring-revenue mix expansion. Thesis is incremental multiple convergence for TMX versus modest competitive and execution pressure at CBOE; stop if CBOE materially outgrows transaction/data revenue expectations or TMX reports migration delays.
• Treat BNS as an event-monitor rather than a direct expression. Watch for advisory, financing, or capital-markets fee disclosures tied to elevated Canadian M&A and issuance activity, but the available information does not establish a sufficiently material earnings sensitivity for a standalone trade.
• Before increasing exposure, require three data points at the next earnings release: acquired-business closing timetable, annualized cost/revenue synergy guidance, and pro forma net-debt/EBITDA. Absent these, the upside case is primarily management-run-rate extrapolation rather than independently verifiable earnings power.